Dideoxyinosine in Children with Symptomatic Human Immunodeficiency Virus Infection

Authors:
  • RHRobert N. Husson
    Robert N. Husson
  • PBPim Brouwers
    Pim Brouwers
  • JEJanie Eddy
    Janie Eddy
  • DEDeborah El-Amin
    Deborah El-Amin
  • JGJanet Gress
    Janet Gress
  • MHMary Hawkins
    Mary Hawkins
  • PJPaul Jarosinski
    Paul Jarosinski
  • HMHoward Moss
    Howard Moss
  • DPDavid Poplack
    David Poplack
  • SSSheila Santacroce
    Sheila Santacroce

Abstract
2′,3′-Dideoxyinosine (ddI) is a dideoxynucleoside with potent activity in vitro against the human immunodeficiency virus (HIV). In initial clinical trials in adults, ddI showed evidence of antiretroviral activity with little hematologic toxicity.

This publication has 19 references indexed in Scilit: